Jefferies Global Healthcare Conference
Logotype for ModivCare Inc

ModivCare (MODV) Jefferies Global Healthcare Conference summary

Event summary combining transcript, slides, and related documents.

Logotype for ModivCare Inc

Jefferies Global Healthcare Conference summary

1 Feb, 2026

Transformation and strategic direction

  • Ongoing transformation since late 2022 aims to capitalize on platform scale and market shift toward home-based and access-focused healthcare.

  • Strategy centers on delivering lowest cost and best member experience, with significant progress in the last 12-18 months.

  • Transformation includes building a strong team, implementing new processes, and leveraging technology.

  • Headwinds from COVID and Medicaid redetermination are largely behind, with focus now on execution.

  • Market tailwinds support growth as healthcare moves outside clinical settings.

NEMT (Non-Emergency Medical Transport) business outlook

  • Shifted from a pure capitated model to a shared risk contract structure, reducing margin volatility.

  • State contracts (~40% of revenue) are stable, with high retention and new wins expected; $600M in state business up for renewal in 2024.

  • MCO business is growing, with $140M in new annual contract value won last year and $32M last quarter.

  • Margin improvement driven by automation, digital integration, and cost reduction; targeting 8% EBITDA margin by year-end, normalizing to 9-10% in 2025+.

  • High single-digit revenue growth expected as business stabilizes post-redetermination.

Execution milestones and cost initiatives

  • Key metrics to watch: payroll per trip and provider costs, both trending down due to automation.

  • Technology adoption (app, text, API integration) reduces call volume and enhances member experience.

  • $30-40M annual cost savings expected, with $60M run rate after full implementation.

  • Continued focus on ecosystem digitization and process standardization.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more